Cargando…
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis
BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detail...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147314/ https://www.ncbi.nlm.nih.gov/pubmed/32296528 http://dx.doi.org/10.1093/ckj/sfz073 |
_version_ | 1783520396030509056 |
---|---|
author | Garam, Nóra Prohászka, Zoltán Szilágyi, Ágnes Aigner, Christof Schmidt, Alice Gaggl, Martina Sunder-Plassmann, Gere Bajcsi, Dóra Brunner, Jürgen Dumfarth, Alexandra Cejka, Daniel Flaschberger, Stefan Flögelova, Hana Haris, Ágnes Hartmann, Ágnes Heilos, Andreas Mueller, Thomas Rusai, Krisztina Arbeiter, Klaus Hofer, Johannes Jakab, Dániel Sinkó, Mária Szigeti, Erika Bereczki, Csaba Janko, Viktor Kelen, Kata Reusz, György S Szabó, Attila J Klenk, Nóra Kóbor, Krisztina Kojc, Nika Knechtelsdorfer, Maarten Laganovic, Mario Lungu, Adrian Catalin Meglic, Anamarija Rus, Rina Kersnik-Levart, Tanja Macioniene, Ernesta Miglinas, Marius Pawłowska, Anna Stompór, Tomasz Podracka, Ludmila Rudnicki, Michael Mayer, Gert Rysava, Romana Reiterova, Jana Saraga, Marijan Seeman, Tomáš Zieg, Jakub Sládková, Eva Szabó, Tamás Capitanescu, Andrei Stancu, Simona Tisljar, Miroslav Galesic, Kresimir Tislér, András Vainumäe, Inga Windpessl, Martin Zaoral, Tomas Zlatanova, Galia Csuka, Dorottya |
author_facet | Garam, Nóra Prohászka, Zoltán Szilágyi, Ágnes Aigner, Christof Schmidt, Alice Gaggl, Martina Sunder-Plassmann, Gere Bajcsi, Dóra Brunner, Jürgen Dumfarth, Alexandra Cejka, Daniel Flaschberger, Stefan Flögelova, Hana Haris, Ágnes Hartmann, Ágnes Heilos, Andreas Mueller, Thomas Rusai, Krisztina Arbeiter, Klaus Hofer, Johannes Jakab, Dániel Sinkó, Mária Szigeti, Erika Bereczki, Csaba Janko, Viktor Kelen, Kata Reusz, György S Szabó, Attila J Klenk, Nóra Kóbor, Krisztina Kojc, Nika Knechtelsdorfer, Maarten Laganovic, Mario Lungu, Adrian Catalin Meglic, Anamarija Rus, Rina Kersnik-Levart, Tanja Macioniene, Ernesta Miglinas, Marius Pawłowska, Anna Stompór, Tomasz Podracka, Ludmila Rudnicki, Michael Mayer, Gert Rysava, Romana Reiterova, Jana Saraga, Marijan Seeman, Tomáš Zieg, Jakub Sládková, Eva Szabó, Tamás Capitanescu, Andrei Stancu, Simona Tisljar, Miroslav Galesic, Kresimir Tislér, András Vainumäe, Inga Windpessl, Martin Zaoral, Tomas Zlatanova, Galia Csuka, Dorottya |
author_sort | Garam, Nóra |
collection | PubMed |
description | BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detailed analysis of functional complement markers. METHODS: A total of 92 patients with clinical, histological, complement and genetic data were involved in the study, and hierarchical cluster analysis was done by Ward method, where four clusters were generated. RESULTS: High levels of sC5b-9 (soluble membrane attack complex), low serum C3 levels and young age at onset (13 years) were characteristic for Cluster 1 with a high prevalence of likely pathogenic variations (LPVs) and C3 nephritic factor, whereas for Cluster 2—which is not reliable because of the small number of cases—strong immunoglobulin G staining, low C3 levels and high prevalence of nephritic syndrome at disease onset were observed. Low plasma sC5b-9 levels, decreased C3 levels and high prevalence of LPV and sclerotic glomeruli were present in Cluster 3, and patients with late onset of the disease (median: 39.5 years) and near-normal C3 levels in Cluster 4. A significant difference was observed in the incidence of end-stage renal disease during follow-up between the different clusters. Patients in Clusters 3–4 had worse renal survival than patients in Clusters 1–2. CONCLUSIONS: Our results confirm the main findings of the original cluster analysis and indicate that the observed, distinct pathogenic patterns are replicated in our cohort. Further investigations are necessary to analyse the distinct biological and pathogenic processes in these patient groups. |
format | Online Article Text |
id | pubmed-7147314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71473142020-04-15 Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis Garam, Nóra Prohászka, Zoltán Szilágyi, Ágnes Aigner, Christof Schmidt, Alice Gaggl, Martina Sunder-Plassmann, Gere Bajcsi, Dóra Brunner, Jürgen Dumfarth, Alexandra Cejka, Daniel Flaschberger, Stefan Flögelova, Hana Haris, Ágnes Hartmann, Ágnes Heilos, Andreas Mueller, Thomas Rusai, Krisztina Arbeiter, Klaus Hofer, Johannes Jakab, Dániel Sinkó, Mária Szigeti, Erika Bereczki, Csaba Janko, Viktor Kelen, Kata Reusz, György S Szabó, Attila J Klenk, Nóra Kóbor, Krisztina Kojc, Nika Knechtelsdorfer, Maarten Laganovic, Mario Lungu, Adrian Catalin Meglic, Anamarija Rus, Rina Kersnik-Levart, Tanja Macioniene, Ernesta Miglinas, Marius Pawłowska, Anna Stompór, Tomasz Podracka, Ludmila Rudnicki, Michael Mayer, Gert Rysava, Romana Reiterova, Jana Saraga, Marijan Seeman, Tomáš Zieg, Jakub Sládková, Eva Szabó, Tamás Capitanescu, Andrei Stancu, Simona Tisljar, Miroslav Galesic, Kresimir Tislér, András Vainumäe, Inga Windpessl, Martin Zaoral, Tomas Zlatanova, Galia Csuka, Dorottya Clin Kidney J Original Articles BACKGROUND: A novel data-driven cluster analysis identified distinct pathogenic patterns in C3-glomerulopathies and immune complex-mediated membranoproliferative glomerulonephritis. Our aim was to replicate these observations in an independent cohort and elucidate disease pathophysiology with detailed analysis of functional complement markers. METHODS: A total of 92 patients with clinical, histological, complement and genetic data were involved in the study, and hierarchical cluster analysis was done by Ward method, where four clusters were generated. RESULTS: High levels of sC5b-9 (soluble membrane attack complex), low serum C3 levels and young age at onset (13 years) were characteristic for Cluster 1 with a high prevalence of likely pathogenic variations (LPVs) and C3 nephritic factor, whereas for Cluster 2—which is not reliable because of the small number of cases—strong immunoglobulin G staining, low C3 levels and high prevalence of nephritic syndrome at disease onset were observed. Low plasma sC5b-9 levels, decreased C3 levels and high prevalence of LPV and sclerotic glomeruli were present in Cluster 3, and patients with late onset of the disease (median: 39.5 years) and near-normal C3 levels in Cluster 4. A significant difference was observed in the incidence of end-stage renal disease during follow-up between the different clusters. Patients in Clusters 3–4 had worse renal survival than patients in Clusters 1–2. CONCLUSIONS: Our results confirm the main findings of the original cluster analysis and indicate that the observed, distinct pathogenic patterns are replicated in our cohort. Further investigations are necessary to analyse the distinct biological and pathogenic processes in these patient groups. Oxford University Press 2019-06-21 /pmc/articles/PMC7147314/ /pubmed/32296528 http://dx.doi.org/10.1093/ckj/sfz073 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Garam, Nóra Prohászka, Zoltán Szilágyi, Ágnes Aigner, Christof Schmidt, Alice Gaggl, Martina Sunder-Plassmann, Gere Bajcsi, Dóra Brunner, Jürgen Dumfarth, Alexandra Cejka, Daniel Flaschberger, Stefan Flögelova, Hana Haris, Ágnes Hartmann, Ágnes Heilos, Andreas Mueller, Thomas Rusai, Krisztina Arbeiter, Klaus Hofer, Johannes Jakab, Dániel Sinkó, Mária Szigeti, Erika Bereczki, Csaba Janko, Viktor Kelen, Kata Reusz, György S Szabó, Attila J Klenk, Nóra Kóbor, Krisztina Kojc, Nika Knechtelsdorfer, Maarten Laganovic, Mario Lungu, Adrian Catalin Meglic, Anamarija Rus, Rina Kersnik-Levart, Tanja Macioniene, Ernesta Miglinas, Marius Pawłowska, Anna Stompór, Tomasz Podracka, Ludmila Rudnicki, Michael Mayer, Gert Rysava, Romana Reiterova, Jana Saraga, Marijan Seeman, Tomáš Zieg, Jakub Sládková, Eva Szabó, Tamás Capitanescu, Andrei Stancu, Simona Tisljar, Miroslav Galesic, Kresimir Tislér, András Vainumäe, Inga Windpessl, Martin Zaoral, Tomas Zlatanova, Galia Csuka, Dorottya Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title | Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title_full | Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title_fullStr | Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title_full_unstemmed | Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title_short | Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
title_sort | validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysis |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147314/ https://www.ncbi.nlm.nih.gov/pubmed/32296528 http://dx.doi.org/10.1093/ckj/sfz073 |
work_keys_str_mv | AT garamnora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT prohaszkazoltan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT szilagyiagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT aignerchristof validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT schmidtalice validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT gagglmartina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT sunderplassmanngere validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT bajcsidora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT brunnerjurgen validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT dumfarthalexandra validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT cejkadaniel validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT flaschbergerstefan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT flogelovahana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT harisagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT hartmannagnes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT heilosandreas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT muellerthomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT rusaikrisztina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT arbeiterklaus validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT hoferjohannes validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT jakabdaniel validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT sinkomaria validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT szigetierika validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT bereczkicsaba validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT jankoviktor validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT kelenkata validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT reuszgyorgys validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT szaboattilaj validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT klenknora validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT koborkrisztina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT kojcnika validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT knechtelsdorfermaarten validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT laganovicmario validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT lunguadriancatalin validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT meglicanamarija validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT rusrina validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT kersniklevarttanja validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT macionieneernesta validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT miglinasmarius validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT pawłowskaanna validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT stomportomasz validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT podrackaludmila validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT rudnickimichael validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT mayergert validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT rysavaromana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT reiterovajana validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT saragamarijan validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT seemantomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT ziegjakub validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT sladkovaeva validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT szabotamas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT capitanescuandrei validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT stancusimona validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT tisljarmiroslav validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT galesickresimir validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT tislerandras validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT vainumaeinga validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT windpesslmartin validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT zaoraltomas validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT zlatanovagalia validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis AT csukadorottya validationofdistinctpathogenicpatternsinacohortofmembranoproliferativeglomerulonephritispatientsbyclusteranalysis |